Characteristics (N) | Clusters (n = 195) | Unique profiles (n = 152) | Univariate logistic regression | |
---|---|---|---|---|
N (%) | N (%) | Crude OR (95% CI) | p value | |
Mean Age in years (SD) | 35.3 (13.5) | 35.6 (13.5) | 1.00 (0.98–1.02) | 0.868 |
Sex | ||||
Male | 140 (71.8) | 110 (72.4) | 1.00 | |
Female | 55 (28.2) | 42 (27.6) | 1.03 (0.64–1.65) | 0.906 |
Nationality | ||||
Brazilian | 160 (82.1) | 106 (69.7) | 1.00 | |
South American migrant | 35 (17.9) | 46 (30.3) | 0.50 (0.30–0.83) | 0.008 |
Education in years | ||||
0–3 | 8 (4.9) | 12 (10.0) | 1.00 | |
4–7 | 52 (31.7) | 36 (30.0) | 2.17 (0.80–5.83) | 0.126 |
8–11 | 81 (49.4) | 50 (41.7) | 2.43 (0.93–6.36) | 0.070 |
12+ | 23 (14.0) | 22 (18.3) | 1.57 (0.54–4.56) | 0.409 |
Worker | ||||
Yes | 140 (77.3) | 109 (77.3) | 1.00 | |
Retired/housewife | 12 (6.6) | 11 (7.8) | 0.85 (0.36–2.00) | 0.708 |
Unemployed | 24 (13.3) | 19 (13.5) | 0.98 (0.51–1.89) | 0.960 |
Prisoners | 5 (2.8) | 2 (1.4) | 1.95 (0.37–10.22) | 0.431 |
PTB incidencea in district of residence | ||||
< 40 | 64 (32.8) | 47 (30.9) | 1.00 | |
40–80 | 74 (38.0) | 55 (36.2) | 0.99 (0.59–1.65) | 0.963 |
> 80 | 57 (29.2) | 50 (32) | 0.84 (0.49–1.43) | 0.515 |
Case type | ||||
New | 145 (75.1) | 117 (80.1) | 1.00 | |
Retreatment/relapse | 48 (24.9) | 29 (19.9) | 1.33 (0.73–2.25) | 0.277 |
Sputum smear | ||||
Negative | 46 (24.3) | 25 (16.7) | 1.00 | |
Positive | 143 (75.7) | 125 (82.3) | 0.62 (0.36–1.07) | 0.086 |
Diagnosis | 184 (94.4) | 140 (92.7) | 1.00 | |
Passive | 11 (5.6) | 11 (7.3) | 0.76 (0.32–1.81) | 0.535 |
Active case finding | ||||
Drug resistance | ||||
No | 158 (89.8) | 122 (85.9) | 1.00 | |
Yes | 18 (10.2) | 20 (14.1) | 0.69 (0.35–1.37) | 0.294 |
Treatment outcome | ||||
Cure | 128 (70.7) | 106 (73.1) | 1.00 | |
Loss of follow-up | 41 (22.7) | 30 (20.7) | 1.13 (0.66–1.94) | 0.651 |
Death/failure | 12 (6.6) | 9 (6.2) | 1.10 (0.45–2.72) | 0.829 |
Household contacts | ||||
0 | 16 (14.7) | 11 (11.5) | 1.00 | |
1–2 | 41 (37.6) | 33 (34.4) | 0.85 (0.35–2.09) | 0.730 |
3–4 | 19 (17.4) | 24 (25.0) | 0.54 (0.20–1.44) | 0.222 |
5+ | 33 (30.3) | 28 (29.2) | 0.81 (0.32–2.03) | 0.653 |
Treatment delay in weeks | ||||
0–2 | 12 (16.0) | 14 (23.7) | 1.00 | |
3–4 | 24 (32.0) | 11 (18.6) | 2.55 (0.89–7.27) | 0.081 |
5–11 | 15 (20.0) | 17 (28.8) | 1.03 (0.36–2.91) | 0.956 |
12 or more | 24 (32.0) | 17 (28.8) | 1.65 (0.62–4.43) | 0.323 |
Alcohol abuse | ||||
No | 166 (85.1) | 131 (86.2) | 1.00 | |
Yes | 30 (14.9) | 21 (13.8) | 1.09 (0.59–2.00) | 0.781 |
Drug use | ||||
No | 154 (79.0) | 135 (88.8) | 1.00 | |
Yes | 41 (21.0) | 17 (11.2) | 2.11 (1.15–3.89) | 0.016 |
TB/HIV co-infection | ||||
No | 126 (70.8) | 106 (79.1) | 1.00 | |
Yes | 52 (29.2) | 28 (20.9) | 1.56 (0.92–2.65) | 0.097 |
Diabetes | ||||
No | 189 (96.9) | 143 (94,1) | 1.00 | |
Yes | 6 (3.1) | 9 (5.9) | 0.50 (0.18–1.45) | 0.204 |